• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆碱能系统、肾上腺素能系统与阿尔茨海默病的神经病理学。

The Cholinergic System, the Adrenergic System and the Neuropathology of Alzheimer's Disease.

机构信息

Department of Biological Sciences, Rutgers University, Newark, NJ 07102, USA.

出版信息

Int J Mol Sci. 2021 Jan 28;22(3):1273. doi: 10.3390/ijms22031273.

DOI:10.3390/ijms22031273
PMID:33525357
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7865740/
Abstract

Neurodegenerative diseases are a major public health problem worldwide with a wide spectrum of symptoms and physiological effects. It has been long reported that the dysregulation of the cholinergic system and the adrenergic system are linked to the etiology of Alzheimer's disease. Cholinergic neurons are widely distributed in brain regions that play a role in cognitive functions and normal cholinergic signaling related to learning and memory is dependent on acetylcholine. The Locus Coeruleus norepinephrine (LC-NE) is the main noradrenergic nucleus that projects and supplies norepinephrine to different brain regions. Norepinephrine has been shown to be neuroprotective against neurodegeneration and plays a role in behavior and cognition. Cholinergic and adrenergic signaling are dysregulated in Alzheimer's disease. The degeneration of cholinergic neurons in nucleus basalis of Meynert in the basal forebrain and the degeneration of LC-NE neurons were reported in Alzheimer's disease. The aim of this review is to describe current literature on the role of the cholinergic system and the adrenergic system (LC-NE) in the pathology of Alzheimer's disease and potential therapeutic implications.

摘要

神经退行性疾病是全球范围内的一个主要公共卫生问题,具有广泛的症状和生理影响。长期以来,人们一直报告说,胆碱能系统和肾上腺素能系统的失调与阿尔茨海默病的病因有关。胆碱能神经元广泛分布于大脑区域,这些区域在认知功能中发挥作用,与学习和记忆相关的正常胆碱能信号取决于乙酰胆碱。蓝斑去甲肾上腺素(LC-NE)是主要的去甲肾上腺素核,它投射并向不同的大脑区域供应去甲肾上腺素。去甲肾上腺素已被证明对神经退行性变具有神经保护作用,并在行为和认知中发挥作用。胆碱能和肾上腺素能信号在阿尔茨海默病中失调。基底前脑的 Meynert 基底核中的胆碱能神经元和 LC-NE 神经元的退化在阿尔茨海默病中已有报道。本综述的目的是描述当前关于胆碱能系统和肾上腺素能系统(LC-NE)在阿尔茨海默病病理学中的作用以及潜在治疗意义的文献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5670/7865740/5c7476d8e1da/ijms-22-01273-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5670/7865740/ac0b6d6c06aa/ijms-22-01273-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5670/7865740/0e9ddd8c9b8e/ijms-22-01273-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5670/7865740/5c7476d8e1da/ijms-22-01273-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5670/7865740/ac0b6d6c06aa/ijms-22-01273-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5670/7865740/0e9ddd8c9b8e/ijms-22-01273-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5670/7865740/5c7476d8e1da/ijms-22-01273-g003.jpg

相似文献

1
The Cholinergic System, the Adrenergic System and the Neuropathology of Alzheimer's Disease.胆碱能系统、肾上腺素能系统与阿尔茨海默病的神经病理学。
Int J Mol Sci. 2021 Jan 28;22(3):1273. doi: 10.3390/ijms22031273.
2
Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease.胆碱能基底核神经元内的预缠结病理学与阿尔茨海默病进展过程中的神经营养和神经递质受体基因失调相一致。
Neurobiol Dis. 2018 Sep;117:125-136. doi: 10.1016/j.nbd.2018.05.021. Epub 2018 May 31.
3
Alzheimer's disease: An evolving understanding of noradrenergic involvement and the promising future of electroceutical therapies.阿尔茨海默病:去甲肾上腺素参与的不断发展的认识和电疗疗法的广阔前景。
Clin Transl Med. 2021 Apr;11(4):e397. doi: 10.1002/ctm2.397.
4
Calbindin-D, parvalbumin, and calretinin in young and aged human locus coeruleus.年轻和老年人类蓝斑中钙结合蛋白-D、副钙蛋白和钙网蛋白。
Neurobiol Aging. 2020 Oct;94:243-249. doi: 10.1016/j.neurobiolaging.2020.06.006. Epub 2020 Jun 15.
5
The toxicity of tumor necrosis factor-alpha upon cholinergic neurons within the nucleus basalis and the role of norepinephrine in the regulation of inflammation: implications for Alzheimer's disease.肿瘤坏死因子-α 对基底核内胆碱能神经元的毒性作用以及去甲肾上腺素在炎症调节中的作用:对阿尔茨海默病的启示
Neuroscience. 2003;121(3):719-29. doi: 10.1016/s0306-4522(03)00545-1.
6
Heightened Hippocampal β-Adrenergic Receptor Function Drives Synaptic Potentiation and Supports Learning and Memory in the TgF344-AD Rat Model during Prodromal Alzheimer's Disease.在阿尔茨海默病前驱期,TgF344-AD 大鼠模型中海马β-肾上腺素能受体功能增强可促进突触强化,并支持学习和记忆。
J Neurosci. 2021 Jun 30;41(26):5747-5761. doi: 10.1523/JNEUROSCI.0119-21.2021. Epub 2021 May 5.
7
α7 nicotinic acetylcholine receptors in Alzheimer's disease: neuroprotective, neurotrophic or both?阿尔茨海默病中的α7 烟碱型乙酰胆碱受体:神经保护、神经营养,还是两者兼具?
Curr Drug Targets. 2012 May;13(5):613-22. doi: 10.2174/138945012800398973.
8
Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease.在去甲肾上腺素能神经元中表达人α-突触核蛋白的转基因小鼠会发展出蓝斑病理和帕金森病的非运动特征。
J Neurosci. 2020 Sep 23;40(39):7559-7576. doi: 10.1523/JNEUROSCI.1468-19.2020. Epub 2020 Aug 31.
9
Norepinephrine metabolite DOPEGAL activates AEP and pathological Tau aggregation in locus coeruleus.去甲肾上腺素代谢产物 DOPEGAL 在蓝斑中激活 AEP 和病理性 Tau 聚集。
J Clin Invest. 2020 Jan 2;130(1):422-437. doi: 10.1172/JCI130513.
10
Complex noradrenergic dysfunction in Alzheimer's disease: Low norepinephrine input is not always to blame.阿尔茨海默病中的复杂去甲肾上腺素能功能障碍:低去甲肾上腺素输入并不总是罪魁祸首。
Brain Res. 2019 Jan 1;1702:12-16. doi: 10.1016/j.brainres.2018.01.001. Epub 2018 Jan 4.

引用本文的文献

1
Hesperidin-β-Cyclodextrin inclusion complexes: A novel approach for preventing and treating acute lung injury caused by seawater drowning.橙皮苷-β-环糊精包合物:一种防治海水淹溺致急性肺损伤的新方法。
Int J Pharm X. 2025 Aug 20;10:100379. doi: 10.1016/j.ijpx.2025.100379. eCollection 2025 Dec.
2
The Janus face of CaMKII: from memory consolidation to neurotoxic switch in Alzheimer's disease.钙调蛋白激酶II的双面性:从记忆巩固到阿尔茨海默病中的神经毒性转变
Arch Toxicol. 2025 Sep 1. doi: 10.1007/s00204-025-04160-7.
3
40 Hz light stimulation restores early brain dynamics alterations and associative memory in Alzheimer's disease model mice.

本文引用的文献

1
α-Adrenergic Receptors in Neurotransmission, Synaptic Plasticity, and Cognition.神经传递、突触可塑性和认知中的α-肾上腺素能受体
Front Pharmacol. 2020 Sep 29;11:581098. doi: 10.3389/fphar.2020.581098. eCollection 2020.
2
Beta-adrenergic receptor antagonism is proinflammatory and exacerbates neuroinflammation in a mouse model of Alzheimer's Disease.β-肾上腺素能受体拮抗作用具有促炎作用,并在阿尔茨海默病的小鼠模型中加重神经炎症。
Neurobiol Dis. 2020 Dec;146:105089. doi: 10.1016/j.nbd.2020.105089. Epub 2020 Sep 22.
3
Proteomics and Neurodegenerative Disorders: Advancements in the Diagnostic Analysis.
40赫兹光刺激可恢复阿尔茨海默病模型小鼠早期大脑动力学改变及联想记忆。
Imaging Neurosci (Camb). 2025 Jul 14;3. doi: 10.1162/IMAG.a.70. eCollection 2025.
4
Golden Oyster Mushroom Extract Ameliorates Oxidative Stress-Induced Cell Death in Neurons and Scopolamine-Induced Cholinergic System Impairment in Mice.金顶侧耳提取物可改善氧化应激诱导的神经元细胞死亡以及东莨菪碱诱导的小鼠胆碱能系统损伤。
Mol Neurobiol. 2025 Jul 19. doi: 10.1007/s12035-025-05223-7.
5
Mill. Mitigates Scopolamine-Induced Cognitive Deficits via Antioxidant and Neuroprotective Mechanisms in Zebrafish.米尔通过斑马鱼体内的抗氧化和神经保护机制减轻东莨菪碱诱导的认知缺陷。
Molecules. 2025 Jul 4;30(13):2858. doi: 10.3390/molecules30132858.
6
Antioxidant, Anti-Inflammatory, and Antiapoptotic Effects of Mart. (Açaí) in Improving Cognition Deficits: Potential Therapeutic Implications for Alzheimer's Disease.玛氏(阿萨伊)的抗氧化、抗炎和抗凋亡作用对改善认知缺陷的影响:对阿尔茨海默病的潜在治疗意义
Plants (Basel). 2025 Jun 30;14(13):2010. doi: 10.3390/plants14132010.
7
Signs of Alzheimer's Disease: Tied to Aging.阿尔茨海默病的迹象:与衰老相关。
Int J Mol Sci. 2025 May 22;26(11):4974. doi: 10.3390/ijms26114974.
8
Sympathetic cholinergic nerve fibres promote BMSC differentiation into osteoblasts via NRTN secretion: a potential treatment for osteoporosis.交感胆碱能神经纤维通过分泌神经营养因子促进骨髓间充质干细胞向成骨细胞分化:一种骨质疏松症的潜在治疗方法。
J Orthop Surg Res. 2025 Jun 5;20(1):571. doi: 10.1186/s13018-025-05944-4.
9
Further In Vitro and Ex Vivo Pharmacological and Kinetic Characterizations of CCF219B: A Positive Allosteric Modulator of the α-Adrenergic Receptor.CCF219B的进一步体外和离体药理学及动力学特性:一种α-肾上腺素能受体的正变构调节剂
Pharmaceuticals (Basel). 2025 Mar 27;18(4):476. doi: 10.3390/ph18040476.
10
Serotonergic Modulators in Alzheimer's Disease: A Hope in the Hopeless Condition.阿尔茨海默病中的5-羟色胺能调节剂:绝望状况下的一线希望
Chem Biodivers. 2025 Aug;22(8):e202403401. doi: 10.1002/cbdv.202403401. Epub 2025 Jun 3.
蛋白质组学与神经退行性疾病:诊断分析的进展。
Curr Protein Pept Sci. 2020;21(12):1174-1183. doi: 10.2174/1389203721666200511094222.
4
Biomarkers for Alzheimer's disease-preparing for a new era of disease-modifying therapies.阿尔茨海默病的生物标志物——为疾病修饰疗法的新时代做准备。
Mol Psychiatry. 2021 Jan;26(1):296-308. doi: 10.1038/s41380-020-0721-9. Epub 2020 Apr 6.
5
Characterization of Alzheimer Disease Biomarker Discrepancies Using Cerebrospinal Fluid Phosphorylated Tau and AV1451 Positron Emission Tomography.使用脑脊液磷酸化tau 和 AV1451 正电子发射断层扫描技术对阿尔茨海默病生物标志物差异进行特征分析。
JAMA Neurol. 2020 Apr 1;77(4):508-516. doi: 10.1001/jamaneurol.2019.4749.
6
Clinical trials of new drugs for Alzheimer disease.治疗阿尔茨海默病新药的临床试验。
J Biomed Sci. 2020 Jan 6;27(1):18. doi: 10.1186/s12929-019-0609-7.
7
Neuroprotective Effects of Choline and Other Methyl Donors.胆碱和其他甲基供体的神经保护作用。
Nutrients. 2019 Dec 6;11(12):2995. doi: 10.3390/nu11122995.
8
Alzheimer's disease-associated (hydroxy)methylomic changes in the brain and blood.阿尔茨海默病相关的(羟)甲基组学改变在大脑和血液中。
Clin Epigenetics. 2019 Nov 27;11(1):164. doi: 10.1186/s13148-019-0755-5.
9
Alpha1-Adrenergic Receptor Mediated Long-Term Depression at CA3-CA1 Synapses Can Be Induced Accumulation of Endogenous Norepinephrine and Is Preserved Following Noradrenergic Denervation.α1-肾上腺素能受体介导的CA3-CA1突触长期抑制可诱导内源性去甲肾上腺素的积累,并在去甲肾上腺素能神经支配丧失后得以保留。
Front Synaptic Neurosci. 2019 Oct 9;11:27. doi: 10.3389/fnsyn.2019.00027. eCollection 2019.
10
A concise review of human brain methylome during aging and neurodegenerative diseases.人类大脑甲基组在衰老和神经退行性疾病过程中的简要综述。
BMB Rep. 2019 Oct;52(10):577-588. doi: 10.5483/BMBRep.2019.52.10.215.